Stock Rating Downgrade
The Value Trend Rating for USANA Health Sciences Inc (NYSE: USNA) weakened in the last week from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
USANA Health Sciences Inc (NYSE: USNA) stock declined by -2.6% on 10/25/24. The shares closed at $36.81. Moreover, above average trading volume at 139% of normal accompanied the decline. The stock has been weak relative to the market over the last nine months but has risen 1.6% during the last week.
Current PriceTarget Research Rating
USNA is expected to continue to be a Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
USANA Health Sciences has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. USANA Health Sciences has a neutral Appreciation Score of 58 but a poor Power Rating of 29, producing the Negative Value Trend Rating.
Be the first to comment